Further studies have indicated that elevated serum ET-1 concentrations are associated with numerous metabolic syndromes, such as obesity, hypertension, uremia, diabetes mellitus, and disorders of the kidney, lung, and liver 16-24. Here, EDN1 is linked to obesity disorder.